We operate in the areas of model-informed drug development, pharmacometrics, clinical pharmacology, statistics, physiologically based pharmacokinetics, quantitative systems pharmacology, biopharmaceutics and regulatory strategy.

Questions that we typically address include: “What concentration levels are necessary in humans?”, “What dose level is associated with the best overall efficacy-safety profile?”, “How can the experimental study design be improved to increase the probability of its success?”…